Nov 28, 2021
Are Pfizer and Moderna going to change their vaccine to Omicron variant (quickly)?
This news has been received from: presstories.com
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
The Omicron variant pushes pharmaceutical companies to update the contents of their vials faster than expected. As the withdrawal campaign is in full swing in some parts of the West, the Govt 19 vaccines are facing a highly contagious new strain and many mutations.
Globally, the B.1.1.529 variant is causing concern as it spreads beyond South Africa, prompting the world to gradually close its borders to South Africa.“There were less than 10 mutations in this protein in the previous variants and the Omigran variant is more than 30. This is worrying, suggesting that this variant should reduce the effectiveness of the vaccine against this new variant,” the virologist pointed out. Etienne Decroly, on L’Express. Moderna in a specific booster dose
According to the expert, it is necessary to anticipate the question of the vaccine, because the current serum is compatible with the original strain of the virus, the latter has developed a lot since 2020. Therefore the vaccine loses its effectiveness. Forms of the disease. “In order to better control the spread of infection and virus, it would be best to adapt the booster shots to the current variants,” Etienne DeCroley continued.
Limited offer. 1 € to 2 months without commitment
Some labs are getting ready: US company Moderna announced on Friday that it intends to develop a specific booster dose for the new Omigron variant of Covit-19, which is considered “worrying” by the WHO. “Moderna will quickly develop a vaccine candidate for a specific booster dose for the Omigran variant,” the U.S. company said in a statement. See also Radeon Technologies is backed by a resumption of air service
This announcement, according to Moderna, is part of a strategy to work on specific booster doses for anxiety variants. “In 2020-2021, it already includes booster doses for delta and beta variants,” the lab said, adding that “it has repeatedly demonstrated its ability to move new candidates to the level of clinical trials in 60-90 days”.
“We have said from the beginning that we need to be proactive in tackling the evolution of the virus in order to fight the epidemic,” Moderna boss Stephen Boncel was quoted as saying in a statement. “The mutations in the Omicron variant are worrying, and we are moving quickly to implement our strategy to combat this variation for several days,” he added.Pfizer reads Omigran
Other industries are also operating. BioNTech, a German laboratory affiliated with Pfizer, said it would study the new variant and “wait two weeks” for the first results of studies to determine whether it can escape vaccine protection. A WHO spokesman said Friday that it would take “several weeks” to understand the spread of the new variant and the extent of the virus.
According to a spokesman for Friday, the two laboratories were “prepared several months in advance to adjust their vaccine within six weeks and deliver the first dose within 100 days.” In fact, Pfizer has confirmed that on a daily basis Release, November 25, He has been testing the updated version of “since August” [son] Vaccine, which targets the complete spike protein of the delta variant.
Team Astrogenogen He, too, split a statement on the issue, declaring that “in close collaboration with the University of Oxford, it has developed a vaccine site that allows it to respond quickly to emerging new strains.” A British scientist who led research on the vaccine said on Saturday that a new serum could be developed “very quickly” against the Omigran variant. See also Uber sells ABG self-driving division to Aurora
Professor Andrew Pollard, director of the Oxford Vaccine Group, considered it “extremely unlikely” that this new variant would spread strongly among people vaccinated with the delta variant “as we saw last year”. But in doing so, he told the BBC, “it could act very quickly,” because “the process of developing a new vaccine is getting better and better.”
For its part, the European Pharmaceuticals Agency (EMA) is not so keen on the idea of a quick update. The European Comptroller and Auditor General said on Friday that plans to modify the vaccine for the new variant of Covit-19, first detected in South Africa, were “premature” because many countries had suspended or banned flights from South Africa.
Follow the analysis and encryption wherever you are
Download the app
The European Pharmaceuticals Association (EMA) says more details are needed to see if a strain containing “multiple mutations” can escape the four vaccines currently approved in the European Union. “We are closely monitoring the newly released B.1.1.529 variant, which contains several mutations in the peak protein of Covit-19,” the EMA, headquartered in Amsterdam, concluded in a statement to AFP.
ChronicAurélien Saussay, environmental economist at the London School of Economics
ChronicBy Marylin Maeso
ChronicBy Pierre Azoline
News Source: presstories.com
Tags: on l’express the omicron variant the omicron variant the new variant booster doses the delta variant this new variant mutations has developed in a statement the vaccine on friday friday that it their vaccine the spread the virus very quickly south africa according the current for the new strategy in order in order
COVID Omicron News: Kids 5-11 need to be fully vaxxed for NYC indoor venues starting Friday
NEW YORK (WABC) -- The Key to NYC vaccination requirement expands to kids 5-11 on Friday.
Children between the ages of 5 and 11 will now need proof of full vaccination, that's two shots for indoor activities.
That includes indoor dining, fitness, and entertainment venues.
RELATED: What are the symptoms of the COVID omicron variant?
Here are more of today's COVID-19 headlines:
23 active duty sailors in the US Navy discharged for refusing COVID-19 vaccine
The Navy said Tuesday that it has discharged 23 active-duty sailors for refusing the coronavirus vaccine, marking the first time it has thrown currently serving sailors out of the military over the mandatory shots.
The discharges came as the Navy released new COVID-19 guidance that requires all deployed sailors and air crew to be vaccinated, but relaxes some quarantine practices on ships based on recommendations from the Centers for Disease Control and Prevention.
Hospital denies heart transplant to man who hasn't gotten COVID-19 vaccine
The family of a Boston man is speaking out after they say their 31-year-old son was struck from a waitlist for a heart transplant because he was not vaccinated against COVID-19.
DJ Ferguson, who was diagnosed with arrhythmia four years ago, was admitted to Brigham and Women's Hospital after suffering heart failure this winter, his parents told ABC News. But after reviewing Ferguson's medical history, which showed he had not received a coronavirus shot, hospital staff told Ferguson that his vaccination status made him ineligible for a new heart, according to his parents.
What to know about BA.2, new omicron subvariant detected in several US states
Even as the omicron COVID-19 variant continues to sweep the globe, scientists are now monitoring a new mutation of omicron, dubbed BA.2. The World Health Organization maintains that BA.2 is not a "variant of concern," meaning there is no current evidence to suggest this new subvariant will worsen COVID-19 transmission, illness severity, or efficacy of vaccines and public health efforts like masking and social distancing. BA.2 numbers around the world are rising, with at least 40 countries reporting cases to a global variant tracking database, but the subvariant has spread rapidly in Denmark and the UK, with almost half of recent cases in Denmark attributed to BA.2. The subvariant has already been detected in several U.S. states, with Washington State confirming two cases Monday.
Americans' trust in science now deeply polarized, poll shows
Republicans' faith in science is falling as Democrats rely on it even more, with a trust gap in science and medicine widening substantially during the COVID-19 pandemic, new survey data shows. It's the largest gap in nearly five decades of polling by the General Social Survey, a widely respected trend survey conducted by NORC at the University of Chicago that has been measuring confidence in institutions since 1972. That is unsurprising to more than a dozen scientists reached for comment by The Associated Press, but it concerns many of them.
"We are living at a time when people would rather put urine or cleaning chemicals in their body than scientifically vetted vaccines," University of Georgia meteorology professor Marshall Shepherd told the AP in an email. "That is a clear convergence of fear, lack of critical thinking, confirmation bias and political tribalism."
Here's how to get free N95 masks from pharmacies or community health centers
The rollout of free N95 masks for the public began this week across the United States, with some pharmacies already handing out the masks and others expecting to do so in the coming days. The program is part of the Biden administration's effort to distribute 400 million free N95 masks from the Strategic National Stockpile via pharmacies and community health centers. The program is expected to be fully up and running by early February.
The masks are arriving at their destinations with accompanying flyers and signage from the US Department of Health and Human Services, which paid for the masks. Here's what you need to know about getting a free N95 mask through this program.
What is MIS-C in children? TX mom shares son's story of 'scary' battle with rare COVID complication
A 6-year-old Houston boy and his mom are reflecting on his scary battle with a rare COVID-19 complication in children that left him hospitalized in the ICU for more than two weeks. Multisystem Inflammatory Syndrome, also known as MIS-C, in children is a rare condition where different parts of the body become inflamed, including the heart, lungs and brain. It usually happens three to four weeks after contracting the virus. It is extremely rare, with only 1% of kids with COVID getting it. Last January, Sara Cantu took her son, Santana, who was 5 at the time, to the hospital when he began experiencing symptoms weeks after contracting COVID.
COVID-19 vaccines do not affect fertility for women or men, study finds
A new study adds to the growing evidence that COVID-19 vaccines are safe for both pregnant people and people hoping to become pregnant. The study, which looked at more than 2,000 couples in the United States and Canada, found "no adverse association" between getting vaccinated against COVID-19 and fertility, for both men and women. On the other hand, men who contract COVID-19 may experience a temporary reduction in fertility. Couples who had a male partner test positive for COVID-19 within 60 days of their partner's menstrual cycle were 18% less likely to conceive in that cycle, according to the study, published on Jan. 20 in the American Journal of Epidemiology.
When am I contagious if infected with omicron?
When am I contagious if infected with omicron? It's not yet clear, but some early data suggests people might become contagious sooner than with earlier variants - possibly within a day after infection. The U.S. Centers for Disease Control and Prevention says people with the coronavirus are most infectious in the few days before and after symptoms develop. But that window of time might happen earlier with omicron, according to some outside experts. That's because omicron appears to cause symptoms faster than previous variants - about three days after infection, on average, according to preliminary studies. Based on previous data, that means people with omicron could start becoming contagious as soon as a day after infection.
MORE CORONAVIRUS COVID-19 COVERAGE
Omicron variant symptoms: what to know even if you are vaccinated
New York City COVID-19 Vaccine Tracker
New Jersey COVID-19 Vaccine Tracker
Centers for Disease Control and Prevention on coronavirus
Submit a News Tip or Question